| |
 |
|
Class Information
Number: 424/177.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Reduced antigenicity, reduced ability to bind complement, or reduced numbers of activated complement components (e.g., free from aggregated, denatured, fragmented, or polymerized immunoglobulins; free from proteolytic enzymes, etc.)
Description: Subject matter involving an immunoglobulin preparation from which aggregated, denatured, fragmented, or polymerized immunoglobulins have been removed or prevented from forming; or from which plasma proteins, such as proteolytic enzymes, that contaminate an immunoglobulin preparation have been removed; or that has been treated to reduce the number of activated complement components.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7611709 |
1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives |
Nov. 3, 2009 |
| 7553938 |
Method of providing a purified, virus safe antibody preparation |
Jun. 30, 2009 |
| 7485303 |
Pharmaceutical composition of F(ab')2 antibody fragments |
Feb. 3, 2009 |
| 7452539 |
Stabilizing polypeptides which have been exposed to urea |
Nov. 18, 2008 |
| 7413739 |
Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
Aug. 19, 2008 |
| 7368542 |
Method of altering the binding specificity of plasma proteins by oxidation-reduction reactions |
May. 6, 2008 |
| 7288254 |
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
Oct. 30, 2007 |
| 7241592 |
Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
Jul. 10, 2007 |
| 7186410 |
Method for preparing human immunoglobulin concentrates for therapeutic use |
Mar. 6, 2007 |
| 7138120 |
Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
Nov. 21, 2006 |
| 7125552 |
Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
Oct. 24, 2006 |
| 7041798 |
Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use |
May. 9, 2006 |
| 7014847 |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
Mar. 21, 2006 |
| 6893639 |
Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates |
May. 17, 2005 |
| 6875848 |
Process for the production of virus-inactivated human gammaglobulin G |
Apr. 5, 2005 |
| 6875432 |
Reduced-viscosity concentrated protein formulations |
Apr. 5, 2005 |
| 6869605 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response |
Mar. 22, 2005 |
| 6849259 |
Polyclonal antibody composition for treating allergy |
Feb. 1, 2005 |
| 6800738 |
Method for making humanized antibodies |
Oct. 5, 2004 |
| 6709655 |
Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof |
Mar. 23, 2004 |
| 6686191 |
Preparation of virally inactivated intravenously injectable immune serum globulin |
Feb. 3, 2004 |
| 6646108 |
Process for isolating IgG and IgA |
Nov. 11, 2003 |
| 6565831 |
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
May. 20, 2003 |
| 6485932 |
Composition comprising immunoglobulin |
Nov. 26, 2002 |
| 6485725 |
Room temperature storable immunoglobulin preparation for intravenous injection |
Nov. 26, 2002 |
| 6281336 |
Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
Aug. 28, 2001 |
| 6252055 |
Concentrated antibody preparation |
Jun. 26, 2001 |
| 6238664 |
Process for stabilizing proteins |
May. 29, 2001 |
| 6165467 |
Stabilized human monoclonal antibody preparation |
Dec. 26, 2000 |
| 6159471 |
Room temperature storable immunoglobulin preparation for intravenous injection |
Dec. 12, 2000 |
| 6136312 |
Method for producing an IgM preparation for intravenous application |
Oct. 24, 2000 |
| 6090380 |
Treatment of rheumatoid arthritis by oral administration of pooled human immunoglobulin |
Jul. 18, 2000 |
| 5972632 |
Anticomplement activity assays |
Oct. 26, 1999 |
| 5871736 |
Liquid immunoglobulin formulations |
Feb. 16, 1999 |
| 5871950 |
Methods of treating autoimmune diseases and transplantation rejection |
Feb. 16, 1999 |
| 5750105 |
Recombinant antibodies for human therapy |
May. 12, 1998 |
| 5612033 |
Methods of treatment using heat-treated IGM antibody preparations |
Mar. 18, 1997 |
| 5510465 |
Heat-treated IgM antibody preparations |
Apr. 23, 1996 |
| 5447722 |
Method for the suppression of an immune response with antigen-MPEG conjugates in nonsensitized individuals |
Sep. 5, 1995 |
| 5256771 |
Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
Oct. 26, 1993 |
| 5234685 |
Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances |
Aug. 10, 1993 |
| 5190752 |
Intravenously administerable polyclonal immunoglobulin preparation containing IgM and method of manufacture |
Mar. 2, 1993 |
| 5177194 |
Process for purifying immune serum globulins |
Jan. 5, 1993 |
| 5132406 |
Method of producing immunoglobulin preparations for intravenous injection |
Jul. 21, 1992 |
| 5122373 |
Immunoglobulin-G-containing fraction |
Jun. 16, 1992 |
| 5094949 |
Use of chymotrypsin for the inactivation of prekallikrein activator |
Mar. 10, 1992 |
| 5087695 |
Immunoglobulin extraction utilizing properties of colloidal solutions |
Feb. 11, 1992 |
| 5075425 |
Process for the preparation of a pharmaceutical which contains IgG, IgA and IgM and can be administered intravenously |
Dec. 24, 1991 |
| 4965068 |
Polyvalent hyperimmunoglobulin preparation |
Oct. 23, 1990 |
| 4902500 |
Stabilization of antibodies |
Feb. 20, 1990 |
|
|
|
